https://doi.org/10.55788/d5c93d16
The pragmatic SCOFF trial randomised 716 participants scheduled for cardiac catheterisation procedures 1:1 to fasting or no fasting before their procedure. The participants were stratified for procedure site and procedure type (i.e. coronary or device intervention). In the fasting arm, participants fasted solid foods for 6 hours and clear liquids for 2 hours. The primary endpoint was a composite of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia. Dr David Ferreira (John Hunter Hospital, Australia) presented the results [1].
With primary endpoint event rates of 19.1% in the fasting arm and 12.0% in the no-fasting arm, non-inferiority of no fasting to fasting was met. “No fasting was even superior to fasting,” added Dr Ferreira. The effect appeared to be spread across the various components of the primary outcome, except for aspiration pneumonia, of which no cases were reported in either arm (see Table). Patient Satisfaction Scores were also in favour of the no fasting arm (mean 11 vs 15; Bayes factor >100). “However, performance bias is likely to have influenced the outcomes of this measure,” commented Dr Ferreira.
Table: Primary composite outcome breakdown [1]
“No fasting was non-inferior and superior to fasting prior to coronary catheterisation and cardiac implantable device-related procedures for the primary composite outcome of aspiration pneumonia, hypotension, hyperglycaemia, and hypoglycaemia,” concluded Dr Ferreira.
- Ferreira D, et al. Safety and care of no fasting prior to catheterisation laboratory procedures: a non-inferiority randomised control trial (SCOFF trial): fasting versus no fasting prior to cardiac catheterisation procedures. HOTLINE 8, ESC Congress 2024, 30 Aug–02 Sept, London, UK.
Copyright ©2024 Medicom Medical Publishers
Posted on
Previous Article
« WESTCOR-POC: Point-of-care hs-troponin testing increases emergency department efficiency Next Article
STEEER-AF: Shockingly low adherence to ESC atrial fibrillation guidelines »
« WESTCOR-POC: Point-of-care hs-troponin testing increases emergency department efficiency Next Article
STEEER-AF: Shockingly low adherence to ESC atrial fibrillation guidelines »
Table of Contents: ESC 2024
Featured articles
Meet the Expert: Dr Abdullahi Mohamed on Iron Deficiency in Patients with HF
2024 ESC Guidelines in a Nutshell
Guidelines for the management of elevated blood pressure and hypertension
Guidelines for the management of chronic coronary syndromes
Guidelines for the management of atrial fibrillation
Guidelines for the management of peripheral artery and aortic diseases
Crossing Borders in Arrhythmia
EPIC-CAD: What is the best antithrombotic approach in high-risk AF plus stable CAD?
OCEANIC-AF: Asundexian inferior to apixaban for ischaemic stroke prevention in AF
MIRACLE-AF: Elegant solution to improve AF care in rural China
SUPPRESS-AF: What is the value of adding LVA ablation to PVI in AF?
Clever Ideas for Coronary Artery Disease
ABYSS: Can beta-blocker safely be interrupted post-MI?
SWEDEGRAFT: Can a no-touch vein harvesting technique improve outcomes in CABG?
Bioadaptor meets expectations in reducing target lesion failures in coronary artery disease
REC-CAGEFREE I: Can we avoid permanent stenting with drug-coated balloons?
OCCUPI: OCT-guided PCI improves outcomes in complex CAD
Highway to Hypertension Control
Low-dose 3-drug pill GMRx2 shows promise in lowering BP
Is administering BP medication in the evening better than in the morning?
VERONICA: Improving BP control in Africa with a simple strategy
High-end Trials in Heart Failure
FINEARTS-HF: Finerenone improves outcomes in heart failure with preserved ejection fraction
MRAs show varied efficacy in heart failure across ejection fractions
MATTERHORN: Transcatheter repair matches surgery for HF with secondary mitral regurgitation
RESHAPE-HF2: Not a “tie-breaker” for TEER in heart failure
Practical Gains in Screening and Diagnostics
STEEER-AF: Shockingly low adherence to ESC atrial fibrillation guidelines
SCOFF: To fast or not to fast, that’s the question
WESTCOR-POC: Point-of-care hs-troponin testing increases emergency department efficiency
PROTEUS: Can AI improve decision-making around stress echocardiography?
RAPIDxAI: Can AI-augmented chest pain assessment improve cardiovascular outcomes?
Miscellaneous Achievements in Cardiology
HELIOS-B: Vutrisiran candidate for SoC in ATTR cardiomyopathy
Does RAS inhibitor discontinuation affect outcomes after non-cardiac surgery?
Novel approach to managing severe tricuspid regurgitation proves its value
NOTION-3: TAVI plus PCI improves outcomes in CAD plus severe aortic stenosis
RHEIA: TAVI outperformed surgery in women with aortic stenosis
Related Articles
November 7, 2024
HELIOS-B: Vutrisiran candidate for SoC in ATTR cardiomyopathy
© 2024 Medicom Medical Publishers. All rights reserved. Terms and Conditions | Privacy Policy
HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com